Although it is clear that the invasive phenotypes of  BRaf mutated melanoma cells are stringently dependent on BRaf-MEK-ERK activation, the downstream effector targets that are required for oncogenic BRaf-mediated melanomagenesis are not well defined. This evidence concerns the gene MAP2K7 and melanoma.